| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/13/2008 | CN100367930C Spontaneously dispersible N-benzoyl staurosporine compositions |
| 02/13/2008 | CN100367927C Drug delivery of phase changing formulation |
| 02/13/2008 | CN100367864C Method for preparing intestine-moisturizing face-beautifying soybean milk tablet with micron pine pollen, cactus powder, ganoderma lucidum powder and wolferry fruit powder |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis |
| 02/12/2008 | US7329775 Compounds and related methods for mutant p53 reactivation |
| 02/12/2008 | US7329771 2,5-xylenol react with an glyoxyl hemiacetyl then etherifying with haloacetic acid ester; Ethyl 2-[4-(2-ethoxy-2-hydroxyethyl)-2,5-dimethylphenoxy] acetate give Ethyl-2-[4-[2-[[-2-hydroxy-2-(4-hydroxyphenyl)-1-methyethyl]amino]ethyl]-2,5-dimethylphenoxy]acetate; high yield; Beta 3-adrenoceptor agonists |
| 02/12/2008 | US7329765 Benzothiophene compounds having antiinfective activity |
| 02/12/2008 | US7329764 Substitute benzothiophene compounds |
| 02/12/2008 | US7329762 Prodrugs of mitotic kinesin inhibitors |
| 02/12/2008 | US7329761 Substituted imides |
| 02/12/2008 | US7329760 CC-1065 analog synthesis |
| 02/12/2008 | US7329759 1-Substituted-[1H-indene-6,1'-cyclopropane]-4-one derivatives: solid tumors and multi-drug resistant tumors; may also be targeted to a particular tumor; can either be cytostatic or cytotoxic to the tumor cells |
| 02/12/2008 | US7329755 especially naphthalene sulfonamides, used for treating asthma |
| 02/12/2008 | US7329754 modulators of the monoamine receptors, in particular the serotonin, dopamine and norepinephrine receptors, and the biogenic amine transporters for serotonin, dopamine and norepinephrine; |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329752 4-(tetrahydrofuran-2-carbonyl)piperazine-1-carboxylic acid 3-{(1S,3R,5R)-3-[(3-isopropyl-2-oxo-2,3-dihydro-benzoimidazole-1-carbonyl)amino]-8-aza-[3.2.1]oct-8-yl}propyl ester; disorder of reduced motility of the gastrointestinal tract |
| 02/12/2008 | US7329750 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 02/12/2008 | US7329749 Piperazinylcarbonylquinolines and -isoquinolines |
| 02/12/2008 | US7329747 Synthesis of olanzapine and intermediates thereof |
| 02/12/2008 | US7329746 Ring structures C6.C6.C13N and C6.C6.C12NO |
| 02/12/2008 | US7329689 Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester |
| 02/12/2008 | US7329688 Natural vitamin E compositions with superior antioxidant potency |
| 02/12/2008 | US7329687 Anticancer agents; antiproliferative agents |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329685 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseases |
| 02/12/2008 | US7329684 Modulators of the receptor for advanced glycated end products and interact with its ligands; antiinflammatory, antidiabetic and antitumor agents; Alzheimer's disease, erectile dysfunction, metastasis; 2-[(1R)-2-(4-Benzyloxyphenyl)-1-amino-1-ethyl]-3-butyl-5-(3-diethylamino-1-propoxy)benzimidazole |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329682 Method for inhibiting 5-lipoxygenase using a benzoxazole derivative |
| 02/12/2008 | US7329681 Inhibitors of IMPDH enzyme |
| 02/12/2008 | US7329680 Heterocycle substituted carboxylic acids |
| 02/12/2008 | US7329679 6-[[1-phenyl-2-(4-pyridinyl)-1H-benzimidazol-6-yl]oxy]hexanoic acid methyl ester; inhibit activation of microglia; neurodegenerative diseases; antiinflammatory agents; Alzheimer's disease, AIDS dementia, stroke |
| 02/12/2008 | US7329678 Benzimidazolyl-pyridine derivatives; Serum and Glucocorticoid-Regulated Kinase 1 inhibitors; 3-(1H-benzimidazol-2-yl)-5-phenylpyridin-2-amine; regulation of electrolyte balance in renal and cardiovascular disease, antiproliferative agents, rheumatoid arthritis, psoriasis, septic shock, bone loss |
| 02/12/2008 | US7329677 2-[3-(4-Methoxypyridin-2-yl)prop-2-yl]-3H-imidazo[4,5-b]pyridine hydrochloride; transcriptional activation of the iNOS-promoter, tissue and organ damage, cytotoxicity reduction |
| 02/12/2008 | US7329676 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | US7329673 selective agonists of (MC-4R); obesity, diabetes, male and female sexual dysfunction, insulin resistance, osteoartritis; long duration of action, side effects reduction; stereoisomers |
| 02/12/2008 | US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329670 downstream effector of p21ras oncogene; N-(1-(4-Methoxyphenyl)-3-tert-butyl-5-pyrazolyl)-N'-(2,3-dichlorophenyl)urea; antitumor, anticarcinogenic, antiproliferative agent; ras protein signal transduction cascade related cancer |
| 02/12/2008 | US7329669 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/12/2008 | US7329668 For therapy of inflammatory diseases, immune diseases, and cancer |
| 02/12/2008 | US7329667 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor |
| 02/12/2008 | US7329666 Antitumor agents |
| 02/12/2008 | US7329665 Quinazolinone derivative |
| 02/12/2008 | US7329664 Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues |
| 02/12/2008 | US7329663 Substituted-triazolopyrimidines as anticancer agents |
| 02/12/2008 | US7329662 Pyrazolo-pyridine |
| 02/12/2008 | US7329661 N-phenyl-3-pyrimidine-amine derivatives |
| 02/12/2008 | US7329660 Phthalazine derivatives for treating inflammatory diseases |
| 02/12/2008 | US7329659 Substituted-1-phthalazinamines as vr-1 antagonists |
| 02/12/2008 | US7329658 Cannabinoid receptor ligands and uses thereof |
| 02/12/2008 | US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/12/2008 | US7329656 Arylthiobenzylpiperidine derivatives |
| 02/12/2008 | US7329655 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent |
| 02/12/2008 | US7329654 Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| 02/12/2008 | US7329653 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 02/12/2008 | US7329652 Janus Kinase JAK2 and JAK3; 4-chloro-6-(3,5-dimethylpiperazin-1-yl)pyrimidine; chemotherapeutic, antiproliferative, antiinflammatory, immunomodulatory agent; allergies, asthma, autoimmune diseases, transplant rejection, rheumatoid arthritis, multiple sclerosis |
| 02/12/2008 | US7329651 Cannabimimetic ligands |
| 02/12/2008 | US7329649 Combinatorial methods for inducing cancer cell death |
| 02/12/2008 | US7329648 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 02/12/2008 | US7329634 pesticides and herbicides; dehalogenation and reduction of 3-[(2-ethyl-4-bromo-6-methyl)phenyl]-5,5-pentamethylenepyrrolidine-2,4-dione with halogenating agent in presence of solvent and free radical initiator; animal pests and crops controlling |
| 02/12/2008 | US7329543 Red blood cells loaded with S-nitrosothiol and uses therefor |
| 02/12/2008 | US7329499 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes |
| 02/12/2008 | US7329423 Compositions comprising thylakoids useful in the modulation of inflammation process |
| 02/12/2008 | US7329411 Ophthalmic compositions containing a synergistic combination of three polymers |
| 02/12/2008 | US7329408 Eliciting HCV-specific antibodies |
| 02/12/2008 | CA2496623C Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives |
| 02/12/2008 | CA2488011C External preparations for treating dermatitis |
| 02/12/2008 | CA2469779C Method for the treatment of bone disorders |
| 02/12/2008 | CA2468033C A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent |
| 02/12/2008 | CA2445306C Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 02/12/2008 | CA2427583C Inhalable formulation of a solution containing a tiotropium salt |
| 02/12/2008 | CA2416823C Antimycotic nail varnish composition |
| 02/12/2008 | CA2402405C Compositions containing alpha-2-adrenergic agonist components |
| 02/12/2008 | CA2385996C Anticancer agents |
| 02/12/2008 | CA2374003C Improved cellular uptake of bioactive agents |
| 02/12/2008 | CA2373473C Electrolyte gels for maintaining hydration and rehydration |
| 02/12/2008 | CA2367909C Use of lipoxin compounds for inhibiting of tnf-(alpha) initiated neutrophil response |
| 02/12/2008 | CA2355854C Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
| 02/12/2008 | CA2346132C Antibacterial agents and process for producing the same |
| 02/12/2008 | CA2341063C Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 02/12/2008 | CA2332922C Enteric coated pharmaceutical composition and method of manufacturing |
| 02/12/2008 | CA2321122C E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof |
| 02/12/2008 | CA2317793C Laxative composition |
| 02/12/2008 | CA2315261C Oral pharmaceutical extended release dosage form |
| 02/12/2008 | CA2303447C Cationic polymers as toxin-binding agents |
| 02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |
| 02/12/2008 | CA2297673C Pharmaceutical compositions containing an effervescent acid-base couple |
| 02/12/2008 | CA2294582C Treatment of diabetes with thiazolidinedione and metformin |
| 02/12/2008 | CA2290992C (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 02/12/2008 | CA2289260C Controlled release of drugs delivered by sublingual or buccal administration |
| 02/12/2008 | CA2288252C Spine distraction implant and method |
| 02/12/2008 | CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them |
| 02/12/2008 | CA2274942C Intraocular lens containing releasable medication |
| 02/12/2008 | CA2267543C Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy |
| 02/12/2008 | CA2261972C Method of breeding high-level lactation dairy cows using rumen-bypassed amino acids |
| 02/12/2008 | CA2260863C Treatment of psychotic disorders |
| 02/12/2008 | CA2258701C Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| 02/12/2008 | CA2238548C Composition and method for alleviating impaired mental function and memory loss in mammals |